Sfoglia per Rivista
[Fanconi-Zinsser's disease associated to Lewandowsky-Lutz's disease (author's transl)]
1981-01-01 LOVISETTO P ;BÜCHI G ;MAIRANO S ;BIARESE V ;ACTIS GC ;ZINA A ;BUNDINO S ;DE MARCHI M
Fattori prognostici nel mieloma multiplo.
1989-01-01 Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede' P; Palumbo A; Pileri A
Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis
1997-01-01 Sivera, P; Roetto, A; Mazza, U; Camaschella, C
Fibrinolytic activity in normal and leukemic myeloid differentiation.
1982-01-01 Ghezzo F; Palumbo A; Pegoraro L
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials
2020-01-01 Larocca, Alessandra; Mina, Roberto; Offidani, Massimo; Liberati, Anna Marina; Ledda, Antonio; Patriarca, Francesca; Evangelista, Andrea; Spada, Stefano; Benevolo, Giulia; Oddolo, Daniela; Innao, Vanessa; Cangialosi, Clotilde; Bernardini, Annalisa; Musto, Pellegrino; Amico, Valeria; Fraticelli, Vincenzo; Paris, Laura; Giuliani, Nicola; Falcone, Antonietta Pia; Zambello, Renato; De Paoli, Lorenzo; Romano, Alessandra; Palumbo, Antonio; Montefusco, Vittorio; Hajek, Roman; Boccadoro, Mario; Bringhen, Sara
FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY
2014-01-01 Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, M; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P
FISH-MLL abnormalities in patients in Acute Myeliodblastic Leukemia and association with FLT3 and MLL internal duplication.
2006-01-01 Giugliano E; Rege-Cambrin G; Scaravaglio P; Diverio D; Serra A; Mancini M; Brunetto V; Ferranti G; Mattioli G; Fava C; Fimognari M; Ulisciani S; Pane F; Lo Coco F; Saglio G.
FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS
2014-01-01 Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Fava, C; Luciano, L; Zaccaria, A; Rossi, Ar; Usala, E; Gozzini, A; Vigneri, P; Cedrone, M; Tiribelli, M; Abruzzese, E; Avanzini, P; Palandri, F; Soverini, S; Alimena, G; Pane, F; Martinelli, G; Cavo, M; Saglio, G; Baccarani, M; Rosti, G
FOXO TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING
2008-01-01 F. Messa; C. Panuzzo; F. Arruga; P. Nicoli; E. Messa; A. Morotti; A. Rotolo; S. Carturan; T. Kalebic; I. Iacobucci; G. Martinelli; E. Bracco; G. Saglio; D. Cilloni
FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN ACUTE MYELOID LEUKEMIA PATIENTS
2008-01-01 Panuzzo C; Arruga F; Messa F; Bracco E; Rotolo A; Nicoli P; Morotti A; Maffè C; Iacobucci I; Martinelli G; Baccarani M; Saglio G; Cilloni D
FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING
2008-01-01 Panuzzo C; Messa F; Arruga F; Bernardoni R; Rotolo A; Carturan S; Nicoli P; Morotti A; Marrè C; Iacobucci I; Martinelli G; Baccarani M; Saglio G; Cilloni D
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma
2006-01-01 Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives
2018-01-01 Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter
FRONT-LINE THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB (FC-O2) IN YOUNG (<= 65 YRS) AND FIT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. RESULTS OF THE PROSPECTIVE PHASE 2 GIMEMA STUDY LLC0911
2017-01-01 Mauro, FR; Molica, S; Zaja, F; Piciocchi, A; Ilariucci, F; Coscia, M; Carella, AM; Re, F; Liberati, AM; Tedeschi, A; Gozzetti, A; Cuneo, A; Cortelezzi, A; Baraldi, A; Del Poeta, G; Musolino, C; Battistini, R; De Propris, MS; Della Starza, I; Raponi, S; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Russo, F; Porrazzo, M; Riemma, C; Specchia, G; Neri, A; Guarini, A; Foa, R
Front-line treatment of Philadelphia positive chronic myeloid leukemia withimatinib and interferon-alpha: 5-year outcome
2008-01-01 Palandri F; Iacobucci I; Castagnetti F; Testoni N; Poerio A; Amabile M; Breccia M; Intermesoli T; Iuliano F; Rege-Cambrin G; Tiribelli M; Miglino M; Pane F; Saglio G; Martinelli G; Rosti G; Baccarani M; GIMEMA Working Party on CML
Gene expression analysis based on real time PCR of 95 genes coding for tyrosine kinases in Ph negative chronic myeloproliferative disorders
2005-01-01 Arruga F; Gottardi E; Fava M; Carturan S; Messa F;Defilippi I; Morotti A; Messa E; Capella S; Chiarenza A; Giugliano E; Saglio G; Cilloni D
Genetic modification of primary chronic lymphocyticleukemia cells with a lentivirus expressing CD38
2010-01-01 Pearce L; Morgan L; Lin TT; Hewamana S; Matthews RJ; Deaglio S; Rowntree C; Fegan C; Pepper C; Brennan P
Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients
2005-01-01 DUFOUR C, SVAHN J, BACIGALUPO A, LONGONI D, VAROTTO S, IORI AP, BAGNASCO F, LOCASCIULLI A, MENNA G, RAMENGHI U, LANCIOTTI M; Associazione Italiana Ematologia ed Oncologia Pediatrica; Dipartimento di Ematologia (Ospedale San Martino Genova Italy)
A genetic score for the prediction of beta-thalassemia severity
2015-01-01 Danjou, Fabrice; Francavilla, Marcella; Anni, Franco; Satta, Stefania; Demartis, Franca-Rosa; Perseu, Lucia; Manca, Matteo; Sollaino, Maria Carla; Manunza, Laura; Mereu, Elisabetta; Marceddu, Giuseppe; Pissard, Serge; Joly, Philippe; Thuret, Isabelle; Origa, Raffaella; Borg, Joseph; Forni, Gian Luca; Piga, Antonio; Lai, Maria Eliana; Badens, Catherine; Moi, Paolo; Galanello, Renzo
Genotype-phenotype association and variant characterization in Diamond Blackfan anemia caused by pathogenic variants in RPL35A
2021-01-01 Matthew Gianferante D.; Wlodarski M.W.; Atsidaftos E.; Da Costa L.; Delaporta P.; Farrar J.E.; Goldman F.D.; Hussain M.; Kattamis A.; Leblanc T.; Lipton J.M.; Niemeyer C.M.; Pospisilova D.; Quarello P.; Ramenghi U.; Sankaran V.G.; Vlachos A.; Volejnikova J.; Alter B.P.; Savage S.A.; Giri N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Fanconi-Zinsser's disease associated to Lewandowsky-Lutz's disease (author's transl)] | 1981 | LOVISETTO P ;BÜCHI G ;MAIRANO S ;BIARESE V ;ACTIS GC ;ZINA A ;BUNDINO S ;DE MARCHI M | |
| Fattori prognostici nel mieloma multiplo. | 1989 | Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede' P; Palumbo A; Pileri A | |
| Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis | 1997 | Sivera, P; Roetto, A; Mazza, U; Camaschella, C | |
| Fibrinolytic activity in normal and leukemic myeloid differentiation. | 1982 | Ghezzo F; Palumbo A; Pegoraro L | |
| First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials | 2020 | Larocca, Alessandra; Mina, Roberto; Offidani, Massimo; Liberati, Anna Marina; Ledda, Antonio; Patriarca, Francesca; Evangelista, Andrea; Spada, Stefano; Benevolo, Giulia; Oddolo, Daniela; Innao, Vanessa; Cangialosi, Clotilde; Bernardini, Annalisa; Musto, Pellegrino; Amico, Valeria; Fraticelli, Vincenzo; Paris, Laura; Giuliani, Nicola; Falcone, Antonietta Pia; Zambello, Renato; De Paoli, Lorenzo; Romano, Alessandra; Palumbo, Antonio; Montefusco, Vittorio; Hajek, Roman; Boccadoro, Mario; Bringhen, Sara | |
| FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY | 2014 | Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, M; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P | |
| FISH-MLL abnormalities in patients in Acute Myeliodblastic Leukemia and association with FLT3 and MLL internal duplication. | 2006 | Giugliano E; Rege-Cambrin G; Scaravaglio P; Diverio D; Serra A; Mancini M; Brunetto V; Ferranti G; Mattioli G; Fava C; Fimognari M; Ulisciani S; Pane F; Lo Coco F; Saglio G. | |
| FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS | 2014 | Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Fava, C; Luciano, L; Zaccaria, A; Rossi, Ar; Usala, E; Gozzini, A; Vigneri, P; Cedrone, M; Tiribelli, M; Abruzzese, E; Avanzini, P; Palandri, F; Soverini, S; Alimena, G; Pane, F; Martinelli, G; Cavo, M; Saglio, G; Baccarani, M; Rosti, G | |
| FOXO TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING | 2008 | F. Messa; C. Panuzzo; F. Arruga; P. Nicoli; E. Messa; A. Morotti; A. Rotolo; S. Carturan; T. Kalebic; I. Iacobucci; G. Martinelli; E. Bracco; G. Saglio; D. Cilloni | |
| FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN ACUTE MYELOID LEUKEMIA PATIENTS | 2008 | Panuzzo C; Arruga F; Messa F; Bracco E; Rotolo A; Nicoli P; Morotti A; Maffè C; Iacobucci I; Martinelli G; Baccarani M; Saglio G; Cilloni D | |
| FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING | 2008 | Panuzzo C; Messa F; Arruga F; Bernardoni R; Rotolo A; Carturan S; Nicoli P; Morotti A; Marrè C; Iacobucci I; Martinelli G; Baccarani M; Saglio G; Cilloni D | |
| Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma | 2006 | Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M | |
| From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives | 2018 | Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter | |
| FRONT-LINE THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB (FC-O2) IN YOUNG (<= 65 YRS) AND FIT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. RESULTS OF THE PROSPECTIVE PHASE 2 GIMEMA STUDY LLC0911 | 2017 | Mauro, FR; Molica, S; Zaja, F; Piciocchi, A; Ilariucci, F; Coscia, M; Carella, AM; Re, F; Liberati, AM; Tedeschi, A; Gozzetti, A; Cuneo, A; Cortelezzi, A; Baraldi, A; Del Poeta, G; Musolino, C; Battistini, R; De Propris, MS; Della Starza, I; Raponi, S; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Russo, F; Porrazzo, M; Riemma, C; Specchia, G; Neri, A; Guarini, A; Foa, R | |
| Front-line treatment of Philadelphia positive chronic myeloid leukemia withimatinib and interferon-alpha: 5-year outcome | 2008 | Palandri F; Iacobucci I; Castagnetti F; Testoni N; Poerio A; Amabile M; Breccia M; Intermesoli T; Iuliano F; Rege-Cambrin G; Tiribelli M; Miglino M; Pane F; Saglio G; Martinelli G; Rosti G; Baccarani M; GIMEMA Working Party on CML | |
| Gene expression analysis based on real time PCR of 95 genes coding for tyrosine kinases in Ph negative chronic myeloproliferative disorders | 2005 | Arruga F; Gottardi E; Fava M; Carturan S; Messa F;Defilippi I; Morotti A; Messa E; Capella S; Chiarenza A; Giugliano E; Saglio G; Cilloni D | |
| Genetic modification of primary chronic lymphocyticleukemia cells with a lentivirus expressing CD38 | 2010 | Pearce L; Morgan L; Lin TT; Hewamana S; Matthews RJ; Deaglio S; Rowntree C; Fegan C; Pepper C; Brennan P | |
| Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients | 2005 | DUFOUR C, SVAHN J, BACIGALUPO A, LONGONI D, VAROTTO S, IORI AP, BAGNASCO F, LOCASCIULLI A, MENNA G, RAMENGHI U, LANCIOTTI M; Associazione Italiana Ematologia ed Oncologia Pediatrica; Dipartimento di Ematologia (Ospedale San Martino Genova Italy) | |
| A genetic score for the prediction of beta-thalassemia severity | 2015 | Danjou, Fabrice; Francavilla, Marcella; Anni, Franco; Satta, Stefania; Demartis, Franca-Rosa; Perseu, Lucia; Manca, Matteo; Sollaino, Maria Carla; Manunza, Laura; Mereu, Elisabetta; Marceddu, Giuseppe; Pissard, Serge; Joly, Philippe; Thuret, Isabelle; Origa, Raffaella; Borg, Joseph; Forni, Gian Luca; Piga, Antonio; Lai, Maria Eliana; Badens, Catherine; Moi, Paolo; Galanello, Renzo | |
| Genotype-phenotype association and variant characterization in Diamond Blackfan anemia caused by pathogenic variants in RPL35A | 2021 | Matthew Gianferante D.; Wlodarski M.W.; Atsidaftos E.; Da Costa L.; Delaporta P.; Farrar J.E.; Goldman F.D.; Hussain M.; Kattamis A.; Leblanc T.; Lipton J.M.; Niemeyer C.M.; Pospisilova D.; Quarello P.; Ramenghi U.; Sankaran V.G.; Vlachos A.; Volejnikova J.; Alter B.P.; Savage S.A.; Giri N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile